Literature DB >> 9589563

Summary of workshop findings for antibodies reacting with porcine T-cells and activation antigens: results from the Second International Swine CD Workshop.

M D Pescovitz1, B K Book, B Aasted, J Dominguez, A Ezquerra, I Trebichavsky, B Novikov, I Valpotic, L Sver, J Nielsen, S Arn, D H Sachs, J K Lunney, P C Boyd, J Walker, R Lee, W Davis, I R Barbosa, F Zuckermann, A Saalmüller.   

Abstract

After initial evaluation of the 176 new and 19 control monoclonal antibodies (mAb) submitted to the Second International Swine CD Workshop, 57 were assigned to the T-cell/activation marker subgroup. These 57 mAb were further analyzed using flow cytometry on whole blood lymphocytes, splenocytes, Peyer's patch lymphocytes, in vitro cell lines, broncho-alveolar lavage cells, Con A and PHA blasts, fetal cell populations, and by 2-color flow cytometry against mAb to porcine CD2, CD4, and CD8. Finally, the molecular weights of the target antigens were characterized when possible. As a result of these analyses, 23 mAb were distributed into 7 CD clusters. Newly confirmed mAb assignments included: two CD2; one CD4; two CD5; one wCD6; and one wCD25. Three new mAb were found that reacted with wCD8, one of which defined a new epitope, wCD8c. For the first time, mAb against porcine CD3 were identified, including 6 mAb that reacted with three different epitopes. Several new mAb reacted with antigens whose expression varied depending on the activation state of the test cell. These will require further characterization in order to assign a CD number.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9589563     DOI: 10.1016/s0165-2427(97)00101-3

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  7 in total

Review 1.  Miniature Swine as a Clinically Relevant Model of Graft-Versus-Host Disease.

Authors:  Raimon Duran-Struuck; Christene A Huang; Katherine Orf; Roderick T Bronson; David H Sachs; Thomas R Spitzer
Journal:  Comp Med       Date:  2015-10       Impact factor: 0.982

2.  An activated immune and inflammatory response targets the pancreas of newborn pigs with cystic fibrosis.

Authors:  Maisam Abu-El-Haija; Marek Sinkora; David K Meyerholz; Michael J Welsh; Paul B McCray; John Butler; Aliye Uc
Journal:  Pancreatology       Date:  2011-11-01       Impact factor: 3.996

3.  Increased levels of anti-non-Gal IgG following pig-to-baboon bone marrow transplantation correlate with failure of engraftment.

Authors:  Fan Liang; Isaac Wamala; Joseph Scalea; Aseda Tena; Taylor Cormack; Shannon Pratts; Raimon Duran-Struuck; Nahel Elias; Martin Hertl; Christene A Huang; David H Sachs
Journal:  Xenotransplantation       Date:  2013-10-29       Impact factor: 3.907

4.  Establishment of transplantable porcine tumor cell lines derived from MHC-inbred miniature swine.

Authors:  Patricia S Cho; Diana P Lo; Krzysztof J Wikiel; Haley C Rowland; Rebecca C Coburn; Isabel M McMorrow; Jennifer G Goodrich; J Scott Arn; Robert A Billiter; Stuart L Houser; Akira Shimizu; Yong-Guang Yang; David H Sachs; Christene A Huang
Journal:  Blood       Date:  2007-08-16       Impact factor: 22.113

5.  Immunophenotyping of leukocyte subsets in peripheral blood and palatine tonsils of prefattening pigs.

Authors:  S Terzić; L Sver; I Valpotić; M Lojkić; Z Miletić; L Jemersić; G Lacković; A Kovsca-Janjatović; N Orsolić
Journal:  Vet Res Commun       Date:  2002-06       Impact factor: 2.459

Review 6.  Contribution of large pig for renal ischemia-reperfusion and transplantation studies: the preclinical model.

Authors:  S Giraud; F Favreau; N Chatauret; R Thuillier; S Maiga; T Hauet
Journal:  J Biomed Biotechnol       Date:  2011-03-03

7.  Induction of influenza-specific local CD8 T-cells in the respiratory tract after aerosol delivery of vaccine antigen or virus in the Babraham inbred pig.

Authors:  Katie Tungatt; Garry Dolton; Sophie B Morgan; Meriem Attaf; Anna Fuller; Thomas Whalley; Johanneke D Hemmink; Emily Porter; Barbara Szomolay; Maria Montoya; John A Hammond; John J Miles; David K Cole; Alain Townsend; Mick Bailey; Pierre J Rizkallah; Bryan Charleston; Elma Tchilian; Andrew K Sewell
Journal:  PLoS Pathog       Date:  2018-05-17       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.